Multiple Endocrine Neoplasia Type 1: Latest Insights.

Brandi, Maria Luisa; Agarwal, Sunita K; Perrier, Nancy D; Lines, Kate E; Valk, Gerlof D; Thakker, Rajesh V

Brandi, Maria Luisa; Agarwal, Sunita K; Perrier, Nancy D; Lines, Kate E; Valk, Gerlof D; Thakker, Rajesh V.

Affiliation

Brandi ML; University of Florence, Florence, Italy.
Agarwal SK; National Institutes of Health, Bethesda, MD, USA.
Perrier ND; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lines KE; University of Oxford, Oxford, UK.
Valk GD; University Medical Center Utrecht, CX Utrecht, the Netherlands.
Thakker RV; University of Oxford, Oxford, UK.

Endocr Rev ; 42(2): 133-170, 2021 03 15.

Article in En | MEDLINE | ID: mdl-33249439

Subject(s)

Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Adolescent; Animals; Germ-Line Mutation; Humans; Mice; Multiple Endocrine Neoplasia Type 1/genetics; Multiple Endocrine Neoplasia Type 1/metabolism; Multiple Endocrine Neoplasia Type 1/pathology; Neuroendocrine Tumors/diagnosis; Neuroendocrine Tumors/genetics; Neuroendocrine Tumors/therapy; Quality of Life; Signal Transduction

Key words

MEN1; epigenetics; menin; mouse models; mutation-negative; neuroendocrine tumors; pharmacological therapies; phenocopy; quality of life; surgical approaches

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Neuroendocrine Tumors / Multiple Endocrine Neoplasia Type 1 Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Adolescent / Animals / Humans Language: En Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google